{
    "Trade/Device Name(s)": [
        "StatStrip Xpress 2 Glucose Hospital Meter System"
    ],
    "Submitter Information": "Nova Biomedical Corporation",
    "510(k) Number": "K182549",
    "Predicate Device Reference 510(k) Number(s)": [
        "K181043"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PZI"
    ],
    "Summary Letter Date": "December 13, 2018",
    "Summary Letter Received Date": "September 17, 2018",
    "Submission Date": "September 14, 2018",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary finger stick",
        "Venous whole blood",
        "Arterial whole blood",
        "Neonate arterial whole blood",
        "Neonate heel stick"
    ],
    "Specimen Container(s)": [
        "Single-use, auto-disabling lancing device"
    ],
    "Instrument(s)/Platform(s)": [
        "StatStrip Xpress 2 Glucose Hospital Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Amperometric enzyme assay (Glucose oxidase)"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for StatStrip Xpress 2 Glucose Hospital Meter System for quantitative glucose determination in whole blood and capillary specimens in hospital settings",
    "Indications for Use Summary": "For point-of-care, in vitro diagnostic, multiple-patient use for quantitative determination of glucose in capillary finger stick, venous whole blood, arterial whole blood, neonate arterial whole blood, and neonate heel stick specimens throughout all hospital and professional healthcare settings, including intensive medical intervention/therapy; not for diabetes diagnosis or neonate cord blood.",
    "fda_folder": "Clinical Chemistry"
}